Innovalve Bio Medical

Company Overview

Snapshot

Founded in August 2018 by Ehud Raanani, Innovalve Bio Medical operated with 11–50 employees. The company was acquired by Edwards Lifesciences in July 2024.

Business overview

Innovalve Bio Medical is an early-stage medical device company specializing in catheter-based heart valve therapies. The company developed an artificial mitral valve designed for minimally invasive replacement to treat heart disease patients. Its technology emerged from inventions and patents by experts at Sheba Medical Center, operating within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

Innovalve Bio Medical's acquisition by Edwards Lifesciences in July 2024 signals a significant validation of its catheter-based heart valve technology. This exit demonstrates the strategic value of its artificial mitral valve in the medical device market and suggests a potential for broader integration of its innovations within a larger multinational framework, impacting future cardiovascular treatment strategies.

Company Intelligence Q&A

What was the most significant corporate event for Innovalve Bio Medical?

Innovalve Bio Medical was acquired by Edwards Lifesciences in July 2024, leading to the cessation of its operations.

Who founded Innovalve Bio Medical?

Innovalve Bio Medical was co-founded by Ehud Raanani.

What is Innovalve Bio Medical's core technology?

Innovalve Bio Medical developed an artificial mitral valve that can be replaced using a minimally invasive catheter for treating heart disease.

When did Innovalve Bio Medical secure its first disclosed funding round?

In August 2020, Innovalve Bio Medical secured a funding round led by.

Which investor participated in multiple funding rounds for Innovalve Bio Medical?

OurCrowd participated in funding rounds for Innovalve Bio Medical in August 2020, June 2021, and March 2022.